StockData
OWPCOTCPharmaceutical PreparationsFiscal year ends December 31

One World Products, Inc.

Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Jan 2, 2026
$0.00+0.00 (+50.00%)

Close on Oct 16, 2026

Market cap
$35.63K
P/E (TTM)
0.0
Dividend yield
0.00%

About One World Products

Pharmaceutical Preparations, SIC 2834

One World Products, Inc. is an emerging growth enterprise engaged in the cannabis industry, focusing on operations that rely on Colombian regulatory licenses, authorizations, and production quotas. The company conducts business activities in connection with entities such as OPW Ventures Inc. and Petalo Pharmaceutical S.A.S. Its activities center on navigating the legal frameworks governing cannabis products and related pharmaceutical or industrial applications, subject to international and local regulatory compliance.

The enterprise maintains its principal executive offices in the United States at 6605 Grand Montecito Parkway, Suite 100, in Las Vegas, Nevada. Its geographic and operational scope extends to Colombia through its dependence on Colombian regulatory guidelines, licenses, and quotas. Specific numbers of operating facilities, customer categories, and retail footprints are not detailed in the provided annual report text.

Summary of the business section of One World Products's latest annual report, written by StockData.

Company profile

Company

Legal name
One World Products, Inc.
Headquarters
Las Vegas, NV
Address
6605 Grand Montecito Pkwy, Suite 100 89149
Phone
(702) 605-0605
Employees
2, Dec 31, 2024
Industry
Pharmaceutical Preparations
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
M&K CPAS, PLLC, Woodlands, TX

Stock & identifiers

Ticker
OWPC
Exchange
OTC
Shares outstanding
120M, Jan 2, 2026
Public float
$3.74M, Jun 30, 2024
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Stock splits
1-for-4 reverse, Jan 10, 2019; 1-for-4 reverse, Jan 10, 2019
SEC CIK
1622244
EIN
61-1744826

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Isiah Thomas IIICEO and Chairman, Director100
Todd A. PetersonChief Financial Officer2,703,535

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 31, 2026Late filingNotification of late filing
Nov 14, 2025Late filingNotification of late filing
Aug 14, 2025Late filingNotification of late filing
Jul 15, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 1, 2025Late filingNotification of late filing
Aug 15, 2024Late filingNotification of late filing
May 17, 2024Late filingNotification of late filing
Apr 1, 2024Late filingNotification of late filing
Jan 19, 2024BankruptcyBankruptcy or receivership (8-K Item 1.03)
Nov 15, 2023Late filingNotification of late filing
Aug 15, 2023Late filingNotification of late filing
May 16, 2023Late filingNotification of late filing
Apr 3, 2023Late filingNotification of late filing
Aug 15, 2022Late filingNotification of late filing
Apr 1, 2022Late filingNotification of late filing
Nov 30, 2021Name changeName changed from One World Pharma, Inc. to One World Products, Inc.
Apr 2, 2021Late filingNotification of late filing
Nov 17, 2020Late filingNotification of late filing
Mar 31, 2020Late filingNotification of late filing
Jul 12, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 12, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 13, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 13, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
May 16, 2019Late filingNotification of late filing
Apr 30, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 30, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 25, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 25, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 8, 2019Name changeName changed from PUNTO GROUP, CORP. to One World Pharma, Inc.
May 16, 2018Late filingNotification of late filing